Tech Company Financing Transactions

Innovative Metabolics Funding Round

Innovative Metabolics closed a $6 million Series A financing round on 6/4/2007. Investors included Flare Capital Partners and Morgenthaler Ventures.

Transaction Overview

Announced On
6/4/2007
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
40 Royal Ave
Cambridge, MA 02138
USA
Website
Email Address
Not Recorded
Overview
The company is developing a neuron-modulation platform to treat a variety of chronic and acute diseases.
Profile
Innovative Metabolics LinkedIn Company Profile
Social Media
Innovative Metabolics Company Twitter Account
Company News
Innovative Metabolics News
Facebook
Innovative Metabolics on Facebook
YouTube
Innovative Metabolics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dominick Colangelo
  Dominick  Colangelo LinkedIn Profile  Dominick  Colangelo Twitter Account  Dominick  Colangelo News  Dominick  Colangelo on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/4/2007: Accu-Break Pharmaceuticals venture capital transaction
Next: 6/4/2007: BioRelix venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary